...
首页> 外文期刊>European Journal of Case Reports in Internal Medicine >Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism
【24h】

Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism

机译:利伐沙班治疗急性肺栓塞后大量自发性血胸

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Spontaneous haemothorax complicating the treatment of pulmonary embolism is rare and potentially fatal. We describe a patient with pulmonary embolism and severe pleuritic pain who developed a life-threatening haemothorax 10 days later while on rivaroxaban therapy. This case highlights the fact that severe pleuritic pain associated with pulmonary embolism may indicate subclinical infarction of tissue near the visceral pleura with an increased risk of pleural effusion and the subsequent development of a haemothorax. It is important to recognise such danger signs warranting closer attention, especially since the increased use of direct oral anticoagulants has facilitated ambulatory care and this complication may manifest in the outpatient setting.
机译:自发性血胸并发肺栓塞的治疗很少见,并且可能致命。我们描述了一名患有肺栓塞和严重胸膜疼痛的患者,该患者在利伐沙班治疗后10天出现了威胁生命的血胸。该病例凸显了以下事实:与肺栓塞相关的严重胸膜痛可能表明内脏胸膜附近的组织出现亚临床梗死,并增加了胸腔积液和随后发生的血胸的风险。重要的是要认识到需要密切注意的危险迹象,尤其是由于增加直接口服口服抗凝剂的使用促进了门诊治疗,这种并发症可能会在门诊病人中表现出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号